Genomic analysis predicts survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in low-grade gliomas
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time,…
Browsing: gliomas
New treatment strategy may benefit patients with brain cancer
Gliomas with mutations in what are called the isocitrate dehydrogenase (IDH) genes are the most…
Australia to lead world-first trial in children with brain cancer
A researcher from UNSW Sydney and Children’s Cancer Institute has received a $1.1 million grant…
Study charts the immune landscape of multiple brain cancers
A Ludwig Cancer Research study has profiled, in a sweeping comparative analysis, the distinct immune…
Study reveals how ‘hypermutated’ malignant brain tumours escape chemotherapy and immunotherapy
Cancers whose cells are riddled with large numbers of DNA mutations often respond favourably to…
How do gliomas evolve?
The Glioma Longitudinal Analysis (GLASS) Consortium characterised diffuse glioma cells both before and after therapy…
ASCO 2019: Suggested benefit in PCV chemoradiotherapy for both IDH-mutant WHO-defined molecular subgroups
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase…
Liquid biopsy of cerebrospinal fluid for the precise characterisation and molecular diagnosis of brain tumours
Published today ahead of print and open access in Clinical Cancer Research, a study led by…
Largest-ever brain cancer study reveals new secrets to inherited risk
Scientists have uncovered a treasure trove of information about the genetic causes of brain cancer…
Low oxygen, high risk: How tumours adapt to become more aggressive
One of the many reasons tumours are so difficult to treat is that they are…